Why This Young contributors’ Epilepsy Drug Is Nearly Surely About to Became the 1st FDA Current Marijuana Treatment
U.K.’s GW Pharmaceuticals is on a bee-line path to an historic, first-ever Food and Drug Administration (FDA) approval for a marijuana-based drug—Epidiolex, which is derived from the cannabis product cannabidiol (CBD) and has shown promise in treating devastating childhood epilepsy and seizure disorders. CBD is different from the euphoric, “high” producing weed component THC. An…

Commentaires récents